Clinical Trials in Arizona

Showing 13161-13180 of 16,770 trials

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

NCT00006348

RATIONALE: Antiemetic drugs, such as ondansetron, may help to reduce or prevent nausea and vomiting in patients with advanced cancer. PURPOSE: This randomized phase III trial is studying how well ondansetron works compared to a placebo in treating patients with advanced cancer and chronic nausea and vomiting that is not caused by cancer therapy.

Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more

Alliance for Clinical Trials in Oncology100 participantsStarted Oct 2000

Scottsdale, Arizona, United States • Urbana, Illinois, United States • Des Moines, Iowa, United States +9 more locations

COMPLETEDPhase 131 miles

Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

NCT00017121

RATIONALE: Inhaling sargramostim may interfere with the growth of tumor cells and may be an effective treatment for melanoma that has spread to the lung. PURPOSE: This phase I trial is studying the side effects and best dose of inhaled sargramostim in treating patients with melanoma that is metastatic to the lung.

Melanoma (Skin)Metastatic Cancer

Alliance for Clinical Trials in Oncology40 participantsStarted May 2002

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Aurora, Illinois, United States +84 more locations

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung

Find Trials by Condition in Arizona

Everolimus in Treating Patients With Stage IV Melanoma

Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed

Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer

Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa

Glycopyrrolate/Formoterol Fumarate MDI Compared With Spiriva® as An Active Control in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC

Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

Fludarabine Followed by Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

Gene Testing in Patients With Colon Cancer

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Peak Study - A Study of Pegasys (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC).

Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke

A Rollover Study of BI 201335 in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-experienced Genotype 1 Hepatitis C Infected Patients

Screening Tests in Detecting Colorectal Cancer